Skip to main content
. 2022 Aug 23;34(11):2751–2759. doi: 10.1007/s40520-022-02223-8

Fig. 1.

Fig. 1

Neuroimaging markers of cerebral small vessel disease. Panel A progression of white matter hyperintensities of presumed vascular origin (fluid-attenuated inversion recovery); Panel B presence of a new lacune of presumed vascular origin in the left basal ganglia (T1-weighted); Panel C progression of enlarged basal-ganglia perivascular spaces in the right basal ganglia (T2-weighted); and Panel D appearance of new cerebral microbleeds (T2*-weighted gradient-recalled echo)